Belapectin, an inhibitor of galectin-3, has no significant effect on liver fibrosis or NASH activity score; however, it lowers HVPG and inhibits the progression of esophageal varices in patients without esophageal varices [203]. The gene discussed is LGALS3; the disease is esophageal varices.